T. Rowe Price Associates’s Quorum Health Corporation QHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-30,042
Closed -$14K 2583
2020
Q1
$14K Buy
30,042
+3,227
+12% +$3.04K ﹤0.01% 2494
2019
Q4
$26K Hold
26,815
﹤0.01% 2510
2019
Q3
$32K Hold
26,815
﹤0.01% 2500
2019
Q2
$37K Sell
26,815
-468
-2% -$768 ﹤0.01% 2528
2019
Q1
$38K Buy
27,283
+100
+0.4% +$269 ﹤0.01% 2510
2018
Q4
$79K Buy
27,183
+83
+0.3% +$348 ﹤0.01% 2501
2018
Q3
$159K Sell
27,100
-37
-0.1% -$170 ﹤0.01% 2490
2018
Q2
$136K Buy
+27,137
New +$174K ﹤0.01% 2501
2018
Q1
Sell
-34,615
Closed -$216K 2604
2017
Q4
$216K Sell
34,615
-12,898
-27% -$64.7K ﹤0.01% 2404
2017
Q3
$246K Hold
47,513
﹤0.01% 2340
2017
Q2
$197K Buy
47,513
+1,818
+4% +$7.46K ﹤0.01% 2388
2017
Q1
$249K Sell
45,695
-4,795
-9% -$39K ﹤0.01% 2323
2016
Q4
$367K Buy
50,490
+15,000
+42% +$90.4K ﹤0.01% 2177
2016
Q3
$223K Buy
35,490
+41
+0.1% +$336 ﹤0.01% 2321
2016
Q2
$380K Buy
+35,449
New +$413K ﹤0.01% 2071

Other funds holding QHC

T. Rowe Price Associates's QHC Position: Q2 2020 in Review

T. Rowe Price Associates sold out of Quorum Health Corporation (QHC) in Q2 2020, closing a stake of 30,042 shares — an estimated $14K sold.

T. Rowe Price Associates first reported a position in QHC in Q2 2016 and held it in 15 quarters. The position peaked at $380K in Q2 2016. 9 funds tracked by Wall St. Rank hold QHC as of Q2 2020.

  • T. Rowe Price Associates reported no remaining Quorum Health Corporation position as of Q2 2020 after selling out during the quarter.
  • T. Rowe Price Associates sold 30,042 Quorum Health Corporation shares in Q2 2020, an estimated $14K.
  • T. Rowe Price Associates first reported a position in Quorum Health Corporation in Q2 2016 and held it in 15 quarters.
  • T. Rowe Price Associates's Quorum Health Corporation position peaked at $380K in Q2 2016.
  • 9 funds tracked by Wall St. Rank held Quorum Health Corporation as of Q2 2020.

Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.